Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Chaves, I. Cerávolo, J. Gomes, C. Zani, A. Romanha, R. Gazzinelli (2001)
IL‐4 and IL‐13 regulate the induction of indoleamine 2,3‐dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN‐γEuropean Journal of Immunology, 31
U. Grohmann, F. Fallarino, P. Puccetti (2003)
Tolerance, DCs and tryptophan: much ado about IDO.Trends in immunology, 24 5
N Novak, C Tepel, S Koch (2003)
Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donorsJ Clin Invest, 111
P Terness, TM Bauer, L Rose (2002)
Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenaseexpressing dendritic cells: mediation of suppression by tryptophan metabolitesJ Exp Med, 196
D Bubnoff, G Bezold, H Matz (2003)
Quanti.cation of indoleamine 2,3-dioxygenase gene induction in atopic and non-atopic monocytes after ligation of the high-af.nity receptor for IgE, Fc(epsilon)RI and interferon-gamma stimulationClin Exp Immunol, 132
J. Kremer, R. Westhovens, M. Léon, E. Giorgio, R. Alten, S. Steinfeld, A. Russell, M. Dougados, P. Emery, I. Nuamah, G. Williams, J. Becker, D. Hagerty, L. Moreland (2003)
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig.The New England journal of medicine, 349 20
F. Fallarino, C. Vacca, C. Orabona, M. Belladonna, R. Bianchi, B. Marshall, D. Keskin, A. Mellor, M. Fioretti, U. Grohmann, P. Puccetti (2002)
Functional expression of indoleamine 2,3-dioxygenase by murine CD8α+ dendritic cellsInternational Immunology, 14
Tricia Babcock, J. Carlin (2000)
Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells.Cytokine, 12 6
G. Lee, Hyeon-Jin Park, M. Macleod, P. Chandler, D. Munn, A. Mellor (2002)
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell divisionImmunology, 107
J. Silva, M. Silva, J. Lefort, B. Vargaftig (2000)
Endotoxins, asthma, and allergic immune responses.Toxicology, 152 1-3
Y. Kudo, C. Boyd (2000)
Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection.Biochimica et biophysica acta, 1500 1
Y Kudo, CA Boyd, I Spyropoulou (2000)
Human placental indoleamine 2,3 dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejectionBiochem Biophys Acta, 61
D. Bubnoff, Rolf Fimmers, M. Bogdanow, H. Matz, Susanne Koch, T. Bieber (2004)
Asymptomatic atopy is associated with increased indoleamine 2,3‐dioxygenase activity and interleukin‐10 production during seasonal allergen exposureClinical & Experimental Allergy, 34
H. Hassanain, S. Chon, S. Gupta (1993)
Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons-gamma and -alpha. Analysis of the regulatory region of the gene and identification of an interferon-gamma-inducible DNA-binding factor.The Journal of biological chemistry, 268 7
R. Steinman, D. Hawiger, M. Nussenzweig (2003)
Tolerogenic dendritic cells.Annual review of immunology, 21
D. Munn, Min Zhou, J. Attwood, I. Bondarev, S. Conway, B. Marshall, Corrie Brown, A. Mellor (1998)
Prevention of allogeneic fetal rejection by tryptophan catabolism.Science, 281 5380
H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, Shintaro Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, S. Akira (2000)
A Toll-like receptor recognizes bacterial DNANature, 408
M. Tosi (2005)
Innate immune responses to infection.The Journal of allergy and clinical immunology, 116 2
U. Grohmann, C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. Belladonna, R. Bianchi, M. Fioretti, P. Puccetti (2002)
CTLA-4–Ig regulates tryptophan catabolism in vivoNature Immunology, 3
A. Mellor, D. Munn (2004)
Ido expression by dendritic cells: tolerance and tryptophan catabolismNature Reviews Immunology, 4
Tomoko Hayashi, L. Beck, C. Rossetto, Xing-mu Gong, O. Takikawa, K. Takabayashi, D. Broide, D. Carson, E. Raz (2004)
Inhibition of experimental asthma by indoleamine 2,3-dioxygenase.The Journal of clinical investigation, 114 2
U Grohmann, R Bianchi, ML Belladonna (2000)
IFN-gamma inhibits presentation of a tumor/self peptide by CD8 alpha-dendritic cells via potentiation of the CD8+ subsetJ Immunol, 165
F. Fallarino, U. Grohmann, C. Vacca, R. Bianchi, C. Orabona, A. Spreca, M. Fioretti, P. Puccetti (2002)
T cell apoptosis by tryptophan catabolismCell Death and Differentiation, 9
D. Munn, Madhav Sharma, A. Mellor (2004)
Ligation of B7-1/B7-2 by Human CD4+ T Cells Triggers Indoleamine 2,3-Dioxygenase Activity in Dendritic Cells1The Journal of Immunology, 172
N. Novak, Carmen Tepel, S. Koch, K. Brix, T. Bieber, S. Kraft (2003)
Evidence for a differential expression of the FcεRIγ chain in dendritic cells of atopic and nonatopic donorsJournal of Clinical Investigation, 111
U. Grohmann, R. Bianchi, M. Belladonna, S. Silla, F. Fallarino, M. Fioretti, P. Puccetti (2000)
IFN-γ Inhibits Presentation of a Tumor/Self Peptide by CD8α− Dendritic Cells Via Potentiation of the CD8α+ Subset1The Journal of Immunology, 165
J Varga, T Yu.t, E Hitraya (1996)
Control of extracellular matrix degradation by inteferon-gamma: the tryptophan connectionAdv Exp Med Biol, 398
D. Bubnoff, H. Bausinger, H. Matz, S. Koch, G. Häcker, O. Takikawa, T. Bieber, D. Hanau, H. Salle (2004)
Human epidermal langerhans cells express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.The Journal of investigative dermatology, 123 2
Gregory Gurtner, R. Newberry, S. Schloemann, Keely McDonald, W. Stenson (2003)
Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice.Gastroenterology, 125 6
D. Bubnoff, G. Bezold, H. Matz, D. Hanau, H. Salle, T. Bieber (2003)
Quantification of indoleamine 2,3‐dioxygenase gene induction in atopic and non‐atopic monocytes after ligation of the high‐affinity receptor for IgE, FcɛRI and interferon‐γ stimulationClinical & Experimental Immunology, 132
T. Musso, G. Gusella, A. Brooks, D. Longo, L. Varesio (1994)
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes.Blood, 83 5
K. Sakurai, J. Zou, J. Tschetter, J. Ward, G. Shearer (2002)
Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 129
D. Bubnoff, H. Matz, C. Frahnert, M. Rao, D. Hanau, H. Salle, T. Bieber (2002)
FcεRI Induces the Tryptophan Degradation Pathway Involved in Regulating T Cell Responses1The Journal of Immunology, 169
S. Fujigaki, Kuniaki Saito, K. Sekikawa, S. Toné, O. Takikawa, H. Fujii, H. Wada, A. Noma, M. Seishima (2001)
Lipopolysaccharide induction of indoleamine 2,3‐dioxygenase is mediated dominantly by an IFN‐γ‐independent mechanismEuropean Journal of Immunology, 31
Mikito Ito, K. Ogawa, K. Takeuchi, A. Nakada, M. Heishi, H. Suto, K. Mitsuishi, Y. Sugita, H. Ogawa, C. Ra (2004)
Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasis.Journal of dermatological science, 36 3
P. Terness, Thomas Bauer, Lars Röse, C. Dufter, A. Watzlik, Helmut Simon, G. Opelz (2002)
Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic CellsThe Journal of Experimental Medicine, 196
F. Yamazaki, T. Kuroiwa, O. Takikawa, R. Kido (1985)
Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme.The Biochemical journal, 230 3
A. Mellor, B. Baban, P. Chandler, B. Marshall, K. Jhaver, A. Hansen, P. Koni, M. Iwashima, D. Munn (2003)
Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion1The Journal of Immunology, 171
S. Odemuyiwa, A. Ghahary, Yunyuan Li, L. Puttagunta, Joo Lee, S. Musat-Marcu, A. Ghahary, R. Moqbel (2004)
Cutting Edge: Human Eosinophils Regulate T Cell Subset Selection through Indoleamine 2,3-Dioxygenase1The Journal of Immunology, 173
A. Alexander, M. Crawford, S. Bertera, W. Rudert, O. Takikawa, P. Robbins, M. Trucco (2002)
Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes.Diabetes, 51 2
D Bubnoff, H Matz, C Frahnert (2002)
FcepsilonRI induces the tryptophan degradation pathway involved in regulating T cell responsesJ Immunol, 169
F. Fallarino, U. Grohmann, K. Hwang, C. Orabona, C. Vacca, R. Bianchi, M. Belladonna, M. Fioretti, M. Alegre, P. Puccetti (2003)
Modulation of tryptophan catabolism by regulatory T cellsNature Immunology, 4
D. Munn, Ebrahim Shafizadeh, J. Attwood, I. Bondarev, A. Pashine, A. Mellor (1999)
Inhibition of T Cell Proliferation by Macrophage Tryptophan CatabolismThe Journal of Experimental Medicine, 189
J. Varga, T. Yufit, E. Hitraya, Raymond Brown (1996)
Control of Extracellular Matrix Degradation by Interferon-γAdvances in Experimental Medicine and Biology, 398
K. Swanson, Yan Zheng, K. Heidler, T. Mizobuchi, D. Wilkes (2004)
CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.American journal of respiratory cell and molecular biology, 30 3
B. Bohle, B. Jahn-Schmid, D. Maurer, D. Kraft, C. Ebner (1999)
Oligodeoxynucleotides containing CpG motifs induce IL‐12, IL‐18 and IFN‐γ production in cells from allergic individuals and inhibit IgE synthesis in vitroEuropean Journal of Immunology, 29
C. Uyttenhove, L. Pilotte, I. Theate, V. Stroobant, D. Colau, Nicolas Parmentier, T. Boon, B. Eynde (2003)
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenaseNature Medicine, 9
D. Bubnoff, D. Hanau, J. Wenzel, O. Takikawa, Brian Hall, S. Koch, T. Bieber (2003)
Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: another piece to the atopic puzzle?The Journal of allergy and clinical immunology, 112 5
Induction of immunologic tolerance is highly desirable in the treatment and prevention of allergy and other immune disease states in which the immune response to foreign or self antigens has become overactive. Indoleamine-2, 3-dioxygenase (IDO), an enzyme classically known for its role in the tryptophan degradation pathway, has recently emerged as an important immunomodulator of T-cell function and inducer of tolerance. The induced expression of IDO by dendritic cells may suppress T-cell responses and promote tolerance either through direct effects on T cells (mediated by tryptophan depletion or tryptophan metabolites) or through effects of IDO on the dendritic cell. In addition to the potential role of IDO in promoting tolerance in pregnancy, transplantation, and autoimmunity, its role in modulating allergic responses has more recently been investigated, raising the possibility that IDO and its metabolites may be novel targets for immunomodulation in allergy and asthma.
Current Allergy and Asthma Reports – Springer Journals
Published: May 27, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.